The world’s first dengue vaccine, Dengvaxia®, was awarded ‘The Vaccine Breakthrough of 2016’ at the 6th annual Biopharma Industry Awards Event last night. Developed by Sanofi Pasteur, Dengvaxia® is the world’s first vaccine licensed for the prevention of dengue caused by all four serotypes in individuals between nine and 45 years of age.
